EMD Serono names VP, medical affairs
This article was originally published in Scrip
Executive Summary
Rockland, Massachusetts-based EMD Serono, the US biopharmaceuticals subsidiary of Germany's Merck KGaA, has appointed Dr Frederick E Munschauer vice-president of medical affairs, neurology and immunology. In this capacity, Dr Munschauer will lead the medical affairs activities for clinical, commercial and business development projects and collaborations for Rebif (interferon beta-1a) as well as the company’s immunology and neurology pipeline. He joins EMD Serono from Biogen, where he was chief medical advisor.